EPHB4 and neoplasm: The intracellular NOTCH domain led JMJD3 to the EPHB4 enhancer region, and modified the chromatin architecture by regulating the H3K27me3 level, which ultimately resulted in EPHB4 activation.120 Recently, JMJD3 has been reported to control tumor immunosuppression.